Jia Lu Wu
Directeur/Membre du Conseil chez Chengdu Aixing Biotech Co. Ltd.
Postes actifs de Jia Lu Wu
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Chengdu Aixing Biotech Co. Ltd.
 Chengdu Aixing Biotech Co. Ltd. Packaged SoftwareTechnology Services Chengdu Aixing Biotech Co. Ltd. is a company founded in 2013 that develops a point of care testing platform. The company is based in Chengdu, China. | Directeur/Membre du Conseil | - | - |
Shanghai Pinnacles Medical Technology Co., Ltd.
 Shanghai Pinnacles Medical Technology Co., Ltd. Medical SpecialtiesHealth Technology Shanghai Pinnacles Medical Technology Co., Ltd. is a company that focuses on becoming a leading enterprise in the field of smart inspection and precise diagnosis. The company is based in Shanghai, China. The Chinese company aims to provide complete solutions for future inspection needs by combining cross-border technologies and focusing on creating a smart inspection and in vitro diagnostic ecosystem. The company was founded in 2020 by Wei Ding, who has been the CEO since 2020. | Directeur/Membre du Conseil | - | - |
Historique de carrière de Jia Lu Wu
Statistiques
Internationale
| Chine | 3 |
Opérationnelle
| Director/Board Member | 2 |
Sectorielle
| Technology Services | 2 |
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Chengdu Aixing Biotech Co. Ltd.
Chengdu Aixing Biotech Co. Ltd. Packaged SoftwareTechnology Services Chengdu Aixing Biotech Co. Ltd. is a company founded in 2013 that develops a point of care testing platform. The company is based in Chengdu, China. | Technology Services |
Shanghai Pinnacles Medical Technology Co., Ltd.
Shanghai Pinnacles Medical Technology Co., Ltd. Medical SpecialtiesHealth Technology Shanghai Pinnacles Medical Technology Co., Ltd. is a company that focuses on becoming a leading enterprise in the field of smart inspection and precise diagnosis. The company is based in Shanghai, China. The Chinese company aims to provide complete solutions for future inspection needs by combining cross-border technologies and focusing on creating a smart inspection and in vitro diagnostic ecosystem. The company was founded in 2020 by Wei Ding, who has been the CEO since 2020. | Health Technology |
